Texas Instruments (TXN) Financials

$150.98 +3.38 (+2.29%)

As of 04/14/2025 04:00 PM Eastern

Annual Income Statements for Texas Instruments

This table shows Texas Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	2,944	3,551	3,649	5,538	4,986	5,568	7,736	8,710	6,477	4,775
Consolidated Net Income / (Loss)	2,986	3,595	3,682	5,580	5,017	5,595	7,769	8,749	6,510	4,799
Net Income / (Loss) Continuing Operations	2,986	3,595	3,682	5,580	5,017	5,595	7,769	8,749	6,510	4,799
Total Pre-Tax Income	4,216	4,930	6,080	6,686	5,728	6,017	8,919	10,032	7,418	5,453
Total Operating Income	4,322	4,855	6,083	6,713	5,723	5,894	8,960	10,140	7,331	5,465
Total Gross Profit	7,575	8,257	9,614	10,277	9,164	9,269	12,376	13,771	11,019	9,094
Total Revenue	13,000	13,370	14,961	15,784	14,383	14,461	18,344	20,028	17,519	15,641
Operating Revenue	13,000	13,370	14,961	15,784	14,383	14,461	18,344	20,028	17,519	15,641
Total Cost of Revenue	5,425	5,113	5,347	5,507	5,219	5,192	5,968	6,257	6,500	6,547
Operating Cost of Revenue	5,425	5,113	5,347	5,507	5,219	5,192	5,968	6,257	6,500	6,547
Total Operating Expenses	3,253	3,402	3,531	3,564	3,441	3,375	3,416	3,631	3,688	3,629
Selling, General & Admin Expense	1,728	1,742	1,694	1,684	1,645	1,647	1,720	1,704	1,825	1,794
Research & Development Expense	1,267	1,356	1,508	1,559	1,544	1,530	1,554	1,670	1,863	1,959
Restructuring Charge	258	304	329	321	-36	-	-	257	0.00	-124
Total Other Income / (Expense), net	-106	75	-3.00	-27	5.00	123	-41	-108	87	-12
Interest Expense	90	80	78	125	170	190	184	214	353	508
Other Income / (Expense), net	-16	155	75	98	175	313	143	106	440	496
Income Tax Expense	1,230	1,335	2,398	1,106	711	422	1,150	1,283	908	654
Preferred Stock Dividends Declared	42	44	33	42	31	27	33	39	33	24
Basic Earnings per Share	$2.86	$3.54	$3.68	$5.71	$5.33	$6.05	$8.38	$9.51	$7.13	$5.24
Weighted Average Basic Shares Outstanding	1.03B	1.00B	991M	970M	936M	921M	923M	916M	908M	912M
Diluted Earnings per Share	$2.82	$3.48	$3.61	$5.59	$5.24	$5.97	$8.26	$9.41	$7.07	$5.20
Weighted Average Diluted Shares Outstanding	1.04B	1.02B	1.01B	990M	952M	933M	936M	926M	916M	919M
Weighted Average Basic & Diluted Shares Outstanding	1.03B	1.00B	991.60M	969.90M	933.98M	920.24M	923.55M	906.21M	909.29M	910.33M
Cash Dividends to Common per Share	$1.40	$1.64	$2.12	$2.63	$3.21	$3.72	$4.21	$4.69	$5.02	$5.26

This table shows Texas Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	2,284	1,953	1,699	1,714	1,699	1,365	1,100	1,121	1,355	1,199
Consolidated Net Income / (Loss)	2,295	1,962	1,708	1,722	1,709	1,371	1,105	1,127	1,362	1,205
Net Income / (Loss) Continuing Operations	2,295	1,962	1,708	1,722	1,709	1,371	1,105	1,127	1,362	1,205
Total Pre-Tax Income	2,658	2,167	1,946	2,002	1,922	1,548	1,293	1,247	1,554	1,359
Total Operating Income	2,678	2,176	1,934	1,972	1,892	1,533	1,286	1,248	1,554	1,377
Total Gross Profit	3,617	3,087	2,863	2,910	2,815	2,431	2,095	2,211	2,474	2,314
Total Revenue	5,241	4,670	4,379	4,531	4,532	4,077	3,661	3,822	4,151	4,007
Operating Revenue	5,241	4,670	4,379	4,531	4,532	4,077	3,661	3,822	4,151	4,007
Total Cost of Revenue	1,624	1,583	1,516	1,621	1,717	1,646	1,566	1,611	1,677	1,693
Operating Cost of Revenue	1,624	1,583	1,516	1,621	1,717	1,646	1,566	1,611	1,677	1,693
Total Operating Expenses	939	911	929	938	923	898	809	963	920	937
Selling, General & Admin Expense	508	220	474	461	452	438	455	465	428	446
Research & Development Expense	431	434	455	477	471	460	478	498	492	491
Total Other Income / (Expense), net	-20	-9.00	12	30	30	15	7.00	-1.00	0.00	-18
Interest Expense	53	60	68	89	98	98	116	131	131	130
Other Income / (Expense), net	33	51	80	119	128	113	123	130	131	112
Income Tax Expense	363	205	238	280	213	177	188	120	192	154
Preferred Stock Dividends Declared	11	9.00	9.00	8.00	10	6.00	5.00	6.00	7.00	6.00
Basic Earnings per Share	$2.50	$2.16	$1.87	$1.89	$1.87	$1.50	$1.21	$1.23	$1.48	$1.32
Weighted Average Basic Shares Outstanding	913M	916M	907M	908M	908M	908M	910M	912M	913M	912M
Diluted Earnings per Share	$2.47	$2.14	$1.85	$1.87	$1.85	$1.50	$1.20	$1.22	$1.47	$1.31
Weighted Average Diluted Shares Outstanding	923M	926M	916M	916M	916M	916M	917M	919M	920M	919M
Weighted Average Basic & Diluted Shares Outstanding	907.57M	906.21M	907.65M	907.97M	908.20M	909.29M	910.48M	913.05M	912.22M	910.33M

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-199	154	502	782	-1.00	670	1,524	-1,581	-86	236
Net Cash From Operating Activities	4,397	4,614	5,363	7,189	6,649	6,139	8,756	8,720	6,420	6,318
Net Cash From Continuing Operating Activities	4,397	4,614	5,366	7,189	6,649	6,139	8,756	8,720	6,420	6,318
Net Income / (Loss) Continuing Operations	2,986	3,595	3,682	5,580	5,017	5,595	7,769	8,749	6,510	4,799
Consolidated Net Income / (Loss)	2,986	3,595	3,682	5,580	5,017	5,595	7,769	8,749	6,510	4,799
Depreciation Expense	766	605	539	590	708	733	755	925	1,175	1,508
Amortization Expense	367	350	365	364	342	259	199	54	63	72
Non-Cash Adjustments To Reconcile Net Income	201	212	242	229	194	220	173	286	362	260
Changes in Operating Assets and Liabilities, net	77	-148	538	426	388	-668	-140	-1,294	-1,690	-321
Net Cash From Investing Activities	-302	-650	-1,127	-78	-1,920	-922	-4,095	-3,583	-4,362	-3,202
Net Cash From Continuing Investing Activities	-302	-650	-1,127	-78	-1,920	-922	-4,095	-3,583	-4,362	-3,202
Purchase of Property, Plant & Equipment	-551	-531	-695	-1,131	-847	-649	-2,462	-2,797	-5,071	-4,820
Purchase of Investments	-2,767	-3,503	-4,555	-5,641	-3,444	-5,786	-10,124	-14,483	-12,705	-9,716
Sale of Property, Plant & Equipment	110	0.00	40	9.00	30	4.00	75	3.00	3.00	195
Sale and/or Maturity of Investments	2,892	3,390	4,095	6,708	2,309	5,545	8,478	13,657	13,387	11,187
Other Investing Activities, net	14	-6.00	-12	-23	32	-36	-62	37	24	-48
Net Cash From Financing Activities	-4,294	-3,810	-3,734	-6,329	-4,730	-4,547	-3,137	-6,718	-2,144	-2,880
Net Cash From Continuing Financing Activities	-4,294	-3,810	-3,734	-6,329	-4,730	-4,547	-3,137	-6,718	-2,144	-2,880
Repayment of Debt	-1,003	-1,003	-656	-547	-792	-536	-596	-541	-557	-653
Repurchase of Common Equity	-2,741	-2,132	-2,556	-5,100	-2,960	-2,553	-527	-3,615	-293	-929
Payment of Dividends	-1,444	-1,646	-2,104	-2,555	-3,008	-3,426	-3,886	-4,297	-4,557	-4,795
Issuance of Debt	498	499	1,099	1,500	1,491	1,498	1,495	1,494	3,000	2,980
Issuance of Common Equity	396	472	483	373	539	470	377	241	263	517

This table details how cash moves in and out of Texas Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-633	-119	1,427	-1,038	-873	398	-481	257	-151	611
Net Cash From Operating Activities	2,766	2,042	1,160	1,399	1,937	1,924	1,017	1,571	1,732	1,998
Net Cash From Continuing Operating Activities	2,766	2,042	1,160	1,399	1,937	1,924	1,017	1,571	1,732	1,998
Net Income / (Loss) Continuing Operations	2,295	1,962	1,708	1,722	1,709	1,371	1,105	1,127	1,362	1,205
Consolidated Net Income / (Loss)	2,295	1,962	1,708	1,722	1,709	1,371	1,105	1,127	1,362	1,205
Depreciation Expense	249	249	265	285	303	322	346	363	383	416
Amortization Expense	13	14	16	15	17	15	16	18	19	19
Non-Cash Adjustments To Reconcile Net Income	68	62	104	110	79	69	-23	119	87	77
Changes in Operating Assets and Liabilities, net	141	-245	-933	-733	-171	147	-427	-56	-119	281
Net Cash From Investing Activities	-2,113	-1,027	28	-2,385	-1,694	-311	-3,329	-	-487	614
Net Cash From Continuing Investing Activities	-2,113	-1,027	28	-2,385	-1,694	-311	-3,329	-	-487	614
Purchase of Property, Plant & Equipment	-790	-967	-982	-1,446	-1,495	-1,148	-1,248	-1,064	-1,316	-1,192
Purchase of Investments	-4,346	-3,688	-3,013	-4,047	-3,080	-2,565	-4,864	-2,098	-1,845	-909
Sale of Property, Plant & Equipment	-	-	1.00	1.00	1.00	-	192	2.00	-	1.00
Sale and/or Maturity of Investments	3,033	3,650	4,026	3,065	2,885	3,411	2,631	3,130	2,700	2,726
Other Investing Activities, net	-10	-22	-4.00	42	-5.00	-9.00	-40	30	-26	-12
Net Cash From Financing Activities	-1,286	-1,134	239	-52	-1,116	-1,215	1,831	-1,314	-1,396	-2,001
Net Cash From Continuing Financing Activities	-1,286	-1,134	239	-52	-1,116	-1,215	1,831	-1,314	-1,396	-2,001
Repayment of Debt	-12	-12	-15	-516	-12	-14	-28	-306	-8.00	-311
Repurchase of Common Equity	-996	-848	-103	-79	-46	-65	-3.00	-71	-318	-537
Payment of Dividends	-1,051	-1,123	-1,125	-1,125	-1,126	-1,181	-1,183	-1,185	-1,187	-1,240
Issuance of Common Equity	78	50	85	65	68	45	65	248	117	87

This table presents Texas Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	16,230	16,431	17,642	17,137	18,018	19,351	24,676	27,207	32,348	35,509
Total Current Assets	7,074	7,457	8,734	8,097	8,761	10,239	13,685	14,021	15,122	15,026
Cash & Equivalents	1,000	1,154	1,656	2,438	2,437	3,107	4,631	3,050	2,964	3,200
Short-Term Investments	2,218	2,336	2,813	1,795	2,950	3,461	5,108	6,017	5,611	4,380
Accounts Receivable	1,165	1,267	1,278	1,207	1,074	1,414	1,701	1,895	1,787	1,719
Inventories, net	1,691	1,790	1,957	2,217	2,001	1,955	1,910	2,757	3,999	4,527
Prepaid Expenses	1,000	910	1,030	440	299	302	335	302	761	1,200
Plant, Property, & Equipment, net	2,596	2,512	2,664	3,183	3,303	3,269	5,141	6,876	9,999	11,347
Plant, Property & Equipment, gross	5,465	4,923	4,789	5,425	5,740	5,781	7,858	9,950	13,268	15,254
Accumulated Depreciation	2,869	2,411	2,125	2,242	2,437	2,512	2,717	3,074	3,269	3,907
Total Noncurrent Assets	6,560	6,462	6,244	5,857	5,954	5,843	5,850	6,310	7,227	9,136
Goodwill	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362
Intangible Assets	1,629	1,316	1,056	717	409	122	85	152	223	257
Noncurrent Deferred & Refundable Income Taxes	201	374	264	295	197	343	263	473	757	936
Employee Benefit Assets	85	96	208	92	218	246	392	188	173	233
Other Noncurrent Operating Assets	62	79	86	140	468	770	748	1,135	1,712	3,348
Total Liabilities & Shareholders' Equity	16,230	16,431	17,642	17,137	18,018	19,351	24,676	27,207	32,348	35,509
Total Liabilities	6,284	5,958	7,305	8,143	9,111	10,164	11,343	12,630	15,451	18,606
Total Current Liabilities	2,555	2,264	2,258	2,474	2,123	2,390	2,569	2,985	3,320	3,643
Short-Term Debt	1,000	631	500	749	500	550	500	500	599	750
Accounts Payable	386	396	466	478	388	415	571	851	802	820
Current Deferred & Payable Income Tax Liabilities	95	83	128	103	46	134	121	189	172	159
Current Employee Benefit Liabilities	664	710	722	724	714	767	775	799	836	839
Other Current Liabilities	410	444	442	420	475	524	602	646	911	1,075
Total Noncurrent Liabilities	3,729	3,694	5,047	5,669	6,988	7,774	8,774	9,645	12,131	14,963
Long-Term Debt	3,120	2,978	3,577	4,319	5,303	6,248	7,241	8,235	10,624	12,846
Noncurrent Deferred & Payable Income Tax Liabilities	37	33	78	42	78	90	87	66	63	53
Noncurrent Employee Benefit Liabilities	196	129	89	118	93	131	79	118	108	110
Other Noncurrent Operating Liabilities	-	554	1,303	1,190	1,514	1,305	1,367	1,226	1,336	1,954
Total Equity & Noncontrolling Interests	9,946	10,473	10,337	8,994	8,907	9,187	13,333	14,577	16,897	16,903
Total Preferred & Common Equity	9,946	10,473	10,337	8,994	8,907	9,187	13,333	14,577	16,897	16,903
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	9,946	10,473	10,337	8,994	8,907	9,187	13,333	14,577	16,897	16,903
Common Stock	3,370	3,415	3,517	3,691	3,851	4,074	4,371	4,692	5,103	5,676
Retained Earnings	31,176	33,107	34,662	37,906	39,898	42,051	45,919	50,353	52,283	52,262
Treasury Stock	-24,068	-25,523	-27,458	-32,130	-34,495	-36,578	-36,800	-40,214	-40,284	-40,895
Accumulated Other Comprehensive Income / (Loss)	-532	-526	-384	-473	-347	-360	-157	-254	-205	-140

This table presents Texas Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	26,057	27,207	29,220	30,939	31,638	32,348	34,885	35,048	35,321	35,509
Total Current Assets	13,772	14,021	15,023	15,514	15,097	15,122	17,448	16,789	15,872	15,026
Cash & Equivalents	3,169	3,050	4,477	3,439	2,566	2,964	2,483	2,740	2,589	3,200
Short-Term Investments	5,921	6,017	5,068	6,113	6,382	5,611	7,910	6,948	6,163	4,380
Accounts Receivable	2,040	1,895	1,877	1,956	1,976	1,787	1,671	1,711	1,862	1,719
Inventories, net	2,404	2,757	3,288	3,729	3,908	3,999	4,083	4,106	4,296	4,527
Prepaid Expenses	238	302	313	277	265	761	1,301	1,284	962	1,200
Plant, Property, & Equipment, net	6,485	6,876	7,665	8,525	9,320	9,999	10,442	11,174	11,802	11,347
Plant, Property & Equipment, gross	9,491	9,950	10,791	11,664	12,528	13,268	13,739	14,622	15,464	15,254
Accumulated Depreciation	3,006	3,074	3,126	3,139	3,208	3,269	3,297	3,448	3,662	3,907
Total Noncurrent Assets	5,800	6,310	6,532	6,900	7,221	7,227	6,995	7,085	7,647	9,136
Goodwill	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362	4,362
Intangible Assets	75	152	140	143	138	223	231	230	229	257
Noncurrent Deferred & Refundable Income Taxes	291	473	486	537	632	757	821	905	941	936
Employee Benefit Assets	273	188	189	183	166	173	169	167	184	233
Other Noncurrent Operating Assets	799	1,135	1,355	1,675	1,923	1,712	1,412	1,421	1,931	3,348
Total Liabilities & Shareholders' Equity	26,057	27,207	29,220	30,939	31,638	32,348	34,885	35,048	35,321	35,509
Total Liabilities	11,550	12,630	13,977	14,999	15,007	15,451	17,902	17,834	18,053	18,606
Total Current Liabilities	2,798	2,985	2,904	2,711	2,652	3,320	3,553	3,637	3,686	3,643
Short-Term Debt	499	500	500	299	300	599	1,349	1,049	1,049	750
Accounts Payable	780	851	952	923	713	802	551	858	794	820
Current Deferred & Payable Income Tax Liabilities	123	189	372	121	108	172	378	178	108	159
Current Employee Benefit Liabilities	662	799	394	561	707	836	399	569	721	839
Other Current Liabilities	734	646	686	807	824	911	876	983	1,014	1,075
Total Noncurrent Liabilities	8,752	9,645	11,073	12,288	12,355	12,131	14,349	14,197	14,367	14,963
Long-Term Debt	7,438	8,235	9,626	10,920	10,922	10,624	12,840	12,842	12,844	12,846
Noncurrent Deferred & Payable Income Tax Liabilities	92	66	73	69	66	63	55	55	54	53
Noncurrent Employee Benefit Liabilities	69	118	123	127	141	108	111	113	117	110
Other Noncurrent Operating Liabilities	1,153	1,226	1,251	1,172	1,226	1,336	1,343	1,187	1,352	1,954
Total Equity & Noncontrolling Interests	14,507	14,577	15,243	15,940	16,631	16,897	16,983	17,214	17,268	16,903
Total Preferred & Common Equity	14,507	14,577	15,243	15,940	16,631	16,897	16,983	17,214	17,268	16,903
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	14,507	14,577	15,243	15,940	16,631	16,897	16,983	17,214	17,268	16,903
Common Stock	4,618	4,692	4,757	4,904	5,021	5,103	5,180	5,407	5,554	5,676
Retained Earnings	49,519	50,353	50,930	51,522	52,098	52,283	52,199	52,135	52,304	52,262
Treasury Stock	-39,476	-40,214	-40,192	-40,240	-40,253	-40,284	-40,193	-40,128	-40,395	-40,895
Accumulated Other Comprehensive Income / (Loss)	-154	-254	-252	-246	-235	-205	-203	-200	-195	-140

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.35%	2.85%	11.90%	5.50%	-8.88%	0.54%	26.85%	9.18%	-12.53%	-10.72%
EBITDA Growth	4.64%	9.67%	18.39%	9.95%	-10.52%	3.61%	39.70%	11.61%	-19.74%	-16.29%
EBIT Growth	8.52%	16.35%	22.91%	10.60%	-13.40%	5.24%	46.66%	12.56%	-24.16%	-23.29%
NOPAT Growth	6.50%	15.66%	4.05%	52.09%	-10.53%	9.34%	42.41%	13.31%	-27.25%	-25.24%
Net Income Growth	5.85%	20.40%	2.42%	51.55%	-10.09%	11.52%	38.86%	12.61%	-25.59%	-26.28%
EPS Growth	9.73%	23.40%	3.74%	54.85%	-6.26%	13.93%	38.36%	13.92%	-24.87%	-26.45%
Operating Cash Flow Growth	8.46%	4.94%	16.23%	34.05%	-7.51%	-7.67%	42.63%	-0.41%	-26.38%	-1.59%
Free Cash Flow Firm Growth	4.29%	3.26%	14.53%	30.65%	-2.35%	-8.64%	15.73%	0.79%	-80.89%	26.63%
Invested Capital Growth	-5.59%	-2.54%	-6.57%	-1.02%	-5.79%	4.37%	20.37%	25.67%	37.21%	17.26%
Revenue Q/Q Growth	-0.61%	1.71%	2.30%	-0.21%	-2.49%	5.29%	4.30%	-0.80%	-3.27%	-0.45%
EBITDA Q/Q Growth	0.15%	5.69%	0.74%	-0.09%	-3.29%	10.19%	5.31%	-2.05%	-5.33%	-0.78%
EBIT Q/Q Growth	1.22%	7.63%	0.90%	-0.47%	-3.86%	12.16%	6.27%	-2.71%	-6.96%	-2.57%
NOPAT Q/Q Growth	1.24%	1.49%	-13.48%	19.11%	-3.60%	10.47%	8.09%	-2.23%	-8.68%	-2.77%
Net Income Q/Q Growth	0.37%	6.24%	-16.03%	19.10%	-3.26%	12.42%	6.15%	-1.97%	-8.32%	-3.34%
EPS Q/Q Growth	1.81%	6.75%	-15.65%	19.44%	-2.42%	12.64%	6.03%	-1.36%	-8.30%	-3.53%
Operating Cash Flow Q/Q Growth	2.93%	-3.59%	11.24%	3.10%	-5.55%	6.43%	2.72%	-3.49%	-1.80%	1.19%
Free Cash Flow Firm Q/Q Growth	2.97%	-7.35%	11.44%	5.96%	-6.75%	5.42%	-11.73%	2.31%	-24.14%	-0.48%
Invested Capital Q/Q Growth	-4.70%	-1.61%	-10.97%	-6.02%	-4.22%	-1.46%	12.14%	6.67%	3.39%	2.28%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	58.27%	61.76%	64.26%	65.11%	63.71%	64.10%	67.47%	68.76%	62.90%	58.14%
EBITDA Margin	41.84%	44.61%	47.20%	49.20%	48.31%	49.78%	54.82%	56.05%	51.42%	48.21%
Operating Margin	33.25%	36.31%	40.66%	42.53%	39.79%	40.76%	48.84%	50.63%	41.85%	34.94%
EBIT Margin	33.12%	37.47%	41.16%	43.15%	41.01%	42.92%	49.62%	51.16%	44.36%	38.11%
Profit (Net Income) Margin	22.97%	26.89%	24.61%	35.35%	34.88%	38.69%	42.35%	43.68%	37.16%	30.68%
Tax Burden Percent	70.83%	72.92%	60.56%	83.46%	87.59%	92.99%	87.11%	87.21%	87.76%	88.01%
Interest Burden Percent	97.91%	98.40%	98.73%	98.16%	97.12%	96.94%	97.98%	97.91%	95.46%	91.48%
Effective Tax Rate	29.17%	27.08%	39.44%	16.54%	12.41%	7.01%	12.89%	12.79%	12.24%	11.99%
Return on Invested Capital (ROIC)	27.98%	33.74%	36.78%	58.19%	53.90%	59.44%	75.22%	69.14%	38.08%	22.65%
ROIC Less NNEP Spread (ROIC-NNEP)	18.27%	53.10%	37.24%	117.49%	55.15%	125.55%	79.26%	77.23%	44.67%	22.41%
Return on Net Nonoperating Assets (RNNOA)	1.39%	1.47%	-1.39%	-0.46%	2.16%	2.40%	-6.22%	-6.45%	3.29%	5.74%
Return on Equity (ROE)	29.37%	35.21%	35.39%	57.73%	56.05%	61.84%	69.00%	62.69%	41.37%	28.40%
Cash Return on Invested Capital (CROIC)	33.73%	36.32%	43.56%	59.22%	59.86%	55.17%	56.73%	46.39%	6.71%	6.76%
Operating Return on Assets (OROA)	25.63%	30.68%	36.15%	39.17%	33.55%	33.22%	41.35%	39.50%	26.10%	17.57%
Return on Assets (ROA)	17.77%	22.01%	21.61%	32.09%	28.54%	29.94%	35.29%	33.73%	21.86%	14.14%
Return on Common Equity (ROCE)	29.37%	35.21%	35.39%	57.73%	56.05%	61.84%	69.00%	62.69%	41.37%	28.40%
Return on Equity Simple (ROE_SIMPLE)	30.02%	34.33%	35.62%	62.04%	56.33%	60.90%	58.27%	60.02%	38.53%	28.39%
Net Operating Profit after Tax (NOPAT)	3,061	3,540	3,684	5,603	5,013	5,481	7,805	8,843	6,434	4,810
NOPAT Margin	23.55%	26.48%	24.62%	35.50%	34.85%	37.90%	42.55%	44.15%	36.72%	30.75%
Net Nonoperating Expense Percent (NNEP)	9.71%	-19.36%	-0.47%	-59.30%	-1.25%	-66.11%	-4.04%	-8.08%	-6.59%	0.24%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	37.93%	22.88%	15.77%
Cost of Revenue to Revenue	41.73%	38.24%	35.74%	34.89%	36.29%	35.90%	32.53%	31.24%	37.10%	41.86%
SG&A Expenses to Revenue	13.29%	13.03%	11.32%	10.67%	11.44%	11.39%	9.38%	8.51%	10.42%	11.47%
R&D to Revenue	9.75%	10.14%	10.08%	9.88%	10.73%	10.58%	8.47%	8.34%	10.63%	12.52%
Operating Expenses to Revenue	25.02%	25.45%	23.60%	22.58%	23.92%	23.34%	18.62%	18.13%	21.05%	23.20%
Earnings before Interest and Taxes (EBIT)	4,306	5,010	6,158	6,811	5,898	6,207	9,103	10,246	7,771	5,961
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5,439	5,965	7,062	7,765	6,948	7,199	10,057	11,225	9,009	7,541
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.41	5.64	8.27	8.60	11.79	14.79	12.05	9.63	8.84	10.05
Price to Tangible Book Value (P/TBV)	11.09	12.32	17.38	19.75	25.40	28.88	18.08	13.94	12.14	13.82
Price to Revenue (P/Rev)	3.37	4.42	5.71	4.90	7.30	9.39	8.76	7.01	8.53	10.86
Price to Earnings (P/E)	14.90	16.63	23.42	13.96	21.07	24.40	20.76	16.11	23.07	35.56
Dividend Yield	3.24%	2.77%	2.44%	3.27%	2.86%	2.51%	2.42%	3.03%	3.05%	2.83%
Earnings Yield	6.71%	6.01%	4.27%	7.16%	4.75%	4.10%	4.82%	6.21%	4.33%	2.81%
Enterprise Value to Invested Capital (EV/IC)	4.19	5.69	8.76	8.14	11.65	14.45	13.99	9.83	7.78	7.67
Enterprise Value to Revenue (EV/Rev)	3.43	4.41	5.67	4.94	7.31	9.41	8.65	6.99	8.68	11.24
Enterprise Value to EBITDA (EV/EBITDA)	8.19	9.88	12.01	10.03	15.13	18.90	15.77	12.47	16.88	23.31
Enterprise Value to EBIT (EV/EBIT)	10.34	11.77	13.77	11.44	17.83	21.92	17.43	13.66	19.57	29.49
Enterprise Value to NOPAT (EV/NOPAT)	14.55	16.65	23.02	13.91	20.98	24.83	20.32	15.83	23.64	36.55
Enterprise Value to Operating Cash Flow (EV/OCF)	10.13	12.78	15.82	10.84	15.81	22.16	18.12	16.05	23.69	27.83
Enterprise Value to Free Cash Flow (EV/FCFF)	12.07	15.47	19.44	13.67	18.89	26.75	26.95	23.59	134.14	122.47
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.41	0.34	0.39	0.56	0.65	0.74	0.58	0.60	0.66	0.80
Long-Term Debt to Equity	0.31	0.28	0.35	0.48	0.60	0.68	0.54	0.56	0.63	0.76
Financial Leverage	0.08	0.03	-0.04	0.00	0.04	0.02	-0.08	-0.08	0.07	0.26
Leverage Ratio	1.65	1.60	1.64	1.80	1.96	2.07	1.96	1.86	1.89	2.01
Compound Leverage Factor	1.62	1.57	1.62	1.77	1.91	2.00	1.92	1.82	1.81	1.84
Debt to Total Capital	29.29%	25.63%	28.29%	36.04%	39.45%	42.53%	36.73%	37.47%	39.91%	44.58%
Short-Term Debt to Total Capital	7.11%	4.48%	3.47%	5.33%	3.40%	3.44%	2.37%	2.14%	2.13%	2.46%
Long-Term Debt to Total Capital	22.18%	21.15%	24.82%	30.71%	36.05%	39.09%	34.36%	35.33%	37.78%	42.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	70.71%	74.37%	71.72%	63.96%	60.55%	57.47%	63.27%	62.53%	60.09%	55.42%
Debt to EBITDA	0.76	0.61	0.58	0.65	0.84	0.94	0.77	0.78	1.25	1.80
Net Debt to EBITDA	0.13	-0.02	-0.09	0.08	0.02	0.03	-0.20	-0.03	0.29	0.80
Long-Term Debt to EBITDA	0.57	0.50	0.51	0.56	0.76	0.87	0.72	0.73	1.18	1.70
Debt to NOPAT	1.35	1.02	1.11	0.90	1.16	1.24	0.99	0.99	1.74	2.83
Net Debt to NOPAT	0.22	-0.03	-0.18	0.10	0.02	0.04	-0.26	-0.04	0.41	1.25
Long-Term Debt to NOPAT	1.02	0.84	0.97	0.77	1.06	1.14	0.93	0.93	1.65	2.67
Altman Z-Score	8.89	10.97	12.21	11.42	12.34	13.35	13.60	11.72	9.84	8.92
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.77	3.29	3.87	3.27	4.13	4.28	5.33	4.70	4.55	4.12
Quick Ratio	1.72	2.10	2.55	2.20	3.04	3.34	4.45	3.67	3.12	2.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3,690	3,810	4,364	5,702	5,568	5,087	5,887	5,933	1,134	1,436
Operating Cash Flow to CapEx	997.05%	868.93%	818.78%	640.73%	813.83%	951.78%	366.82%	312.10%	126.68%	136.61%
Free Cash Flow to Firm to Interest Expense	41.00	47.63	55.95	45.61	32.75	26.77	31.99	27.73	3.21	2.83
Operating Cash Flow to Interest Expense	48.86	57.68	68.76	57.51	39.11	32.31	47.59	40.75	18.19	12.44
Operating Cash Flow Less CapEx to Interest Expense	43.96	51.04	60.36	48.54	34.31	28.92	34.61	27.69	3.83	3.33
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.77	0.82	0.88	0.91	0.82	0.77	0.83	0.77	0.59	0.46
Accounts Receivable Turnover	10.78	11.00	11.76	12.70	12.61	11.62	11.78	11.14	9.52	8.92
Inventory Turnover	3.12	2.94	2.85	2.64	2.47	2.62	3.09	2.68	1.92	1.54
Fixed Asset Turnover	4.78	5.23	5.78	5.40	4.44	4.40	4.36	3.33	2.08	1.47
Accounts Payable Turnover	13.18	13.08	12.41	11.67	12.05	12.93	12.11	8.80	7.86	8.07
Days Sales Outstanding (DSO)	33.85	33.20	31.04	28.73	28.94	31.40	30.99	32.77	38.36	40.91
Days Inventory Outstanding (DIO)	116.90	124.25	127.89	138.32	147.50	139.05	118.19	136.12	189.69	237.67
Days Payable Outstanding (DPO)	27.69	27.91	29.42	31.28	30.28	28.23	30.15	41.48	46.41	45.21
Cash Conversion Cycle (CCC)	123.06	129.53	129.51	135.77	146.16	142.23	119.03	127.42	181.63	233.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	10,627	10,357	9,677	9,578	9,023	9,417	11,335	14,245	19,545	22,919
Invested Capital Turnover	1.19	1.27	1.49	1.64	1.55	1.57	1.77	1.57	1.04	0.74
Increase / (Decrease) in Invested Capital	-629	-270	-680	-99	-555	394	1,918	2,910	5,300	3,374
Enterprise Value (EV)	44,534	58,954	84,816	77,917	105,150	136,070	158,627	139,990	152,067	175,810
Market Capitalization	43,853	59,070	85,476	77,333	105,034	135,840	160,625	140,322	149,419	169,794
Book Value per Share	$9.80	$10.48	$10.49	$9.36	$9.53	$10.01	$14.44	$16.06	$18.60	$18.53
Tangible Book Value per Share	$3.90	$4.80	$4.99	$4.08	$4.42	$5.12	$9.62	$11.09	$13.56	$13.47
Total Capital	14,066	14,082	14,414	14,062	14,710	15,985	21,074	23,312	28,120	30,499
Total Debt	4,120	3,609	4,077	5,068	5,803	6,798	7,741	8,735	11,223	13,596
Total Long-Term Debt	3,120	2,978	3,577	4,319	5,303	6,248	7,241	8,235	10,624	12,846
Net Debt	681	-116	-660	584	116	230	-1,998	-332	2,648	6,016
Capital Expenditures (CapEx)	441	531	655	1,122	817	645	2,387	2,794	5,068	4,625
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,301	2,334	2,507	2,139	1,751	1,831	1,877	2,469	3,826	4,553
Debt-free Net Working Capital (DFNWC)	5,519	5,824	6,976	6,372	7,138	8,399	11,616	11,536	12,401	12,133
Net Working Capital (NWC)	4,519	5,193	6,476	5,623	6,638	7,849	11,116	11,036	11,802	11,383
Net Nonoperating Expense (NNE)	75	-55	1.82	23	-4.38	-114	36	94	-76	11
Net Nonoperating Obligations (NNO)	681	-116	-660	584	116	230	-1,998	-332	2,648	6,016
Total Depreciation and Amortization (D&A)	1,133	955	904	954	1,050	992	954	979	1,238	1,580
Debt-free, Cash-free Net Working Capital to Revenue	17.70%	17.46%	16.76%	13.55%	12.17%	12.66%	10.23%	12.33%	21.84%	29.11%
Debt-free Net Working Capital to Revenue	42.45%	43.56%	46.63%	40.37%	49.63%	58.08%	63.32%	57.60%	70.79%	77.57%
Net Working Capital to Revenue	34.76%	38.84%	43.29%	35.62%	46.15%	54.28%	60.60%	55.10%	67.37%	72.78%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$5.33	$6.05	$8.38	$9.51	$7.13	$5.24
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	0.00	936M	921M	923M	916M	908M	912M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$5.24	$5.97	$8.26	$9.41	$7.07	$5.20
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	0.00	952M	933M	936M	926M	916M	919M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	933.98M	920.24M	923.55M	906.21M	909.29M	910.33M
Normalized Net Operating Profit after Tax (NOPAT)	3,244	3,762	3,883	5,870	4,981	5,481	7,805	9,067	6,434	4,700
Normalized NOPAT Margin	24.95%	28.14%	25.95%	37.19%	34.63%	37.90%	42.55%	45.27%	36.72%	30.05%
Pre Tax Income Margin	32.43%	36.87%	40.64%	42.36%	39.82%	41.61%	48.62%	50.09%	42.34%	34.86%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	47.84	62.63	78.95	54.49	34.69	32.67	49.47	47.88	22.01	11.73
NOPAT to Interest Expense	34.01	44.25	47.23	44.82	29.49	28.85	42.42	41.32	18.23	9.47
EBIT Less CapEx to Interest Expense	42.94	55.99	70.55	45.51	29.89	29.27	36.50	34.82	7.66	2.63
NOPAT Less CapEx to Interest Expense	29.11	37.62	38.83	35.84	24.68	25.45	29.44	28.27	3.87	0.36
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	48.36%	45.79%	57.14%	45.79%	59.96%	61.23%	50.02%	49.11%	70.00%	99.92%
Augmented Payout Ratio	140.15%	105.09%	126.56%	137.19%	118.96%	106.86%	56.80%	90.43%	74.50%	119.27%

This table displays calculated financial ratios and metrics derived from Texas Instruments' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.88%	-3.35%	-10.72%	-13.07%	-13.53%	-12.70%	-16.40%	-15.65%	-8.41%	-1.72%
EBITDA Growth	15.55%	-8.62%	-17.80%	-19.49%	-21.29%	-20.36%	-22.83%	-26.43%	-10.81%	-2.98%
EBIT Growth	16.85%	-11.35%	-21.88%	-23.41%	-25.49%	-26.09%	-30.04%	-34.10%	-16.58%	-9.54%
NOPAT Growth	17.21%	-9.32%	-23.99%	-27.10%	-27.24%	-31.09%	-35.26%	-33.50%	-19.04%	-10.07%
Net Income Growth	17.87%	-8.23%	-22.40%	-24.84%	-25.53%	-30.12%	-35.30%	-34.55%	-20.30%	-12.11%
EPS Growth	19.32%	-5.73%	-21.28%	-23.67%	-25.10%	-29.91%	-35.14%	-34.76%	-20.54%	-12.67%
Operating Cash Flow Growth	13.92%	-13.36%	-45.90%	-20.87%	-29.97%	-5.78%	-12.33%	12.29%	-10.58%	3.85%
Free Cash Flow Firm Growth	-165.68%	-468.97%	-7,598.53%	-387.05%	-314.32%	-319.46%	-75.87%	9.44%	44.63%	45.39%
Invested Capital Growth	32.11%	25.67%	32.60%	35.97%	41.57%	37.21%	31.31%	21.64%	18.53%	17.26%
Revenue Q/Q Growth	0.56%	-10.89%	-6.23%	3.47%	0.02%	-10.04%	-10.20%	4.40%	8.61%	-3.47%
EBITDA Q/Q Growth	0.10%	-16.25%	-7.83%	4.18%	-2.13%	-15.26%	-10.69%	-0.68%	18.65%	-7.81%
EBIT Q/Q Growth	-0.70%	-17.85%	-9.56%	3.82%	-3.40%	-18.51%	-14.40%	-2.20%	22.28%	-11.63%
NOPAT Q/Q Growth	-0.63%	-14.80%	-13.84%	-0.07%	-0.82%	-19.30%	-19.05%	2.63%	20.76%	-10.36%
Net Income Q/Q Growth	0.17%	-14.51%	-12.95%	0.82%	-0.75%	-19.78%	-19.40%	1.99%	20.85%	-11.53%
EPS Q/Q Growth	0.82%	-13.36%	-13.55%	1.08%	-1.07%	-18.92%	-20.00%	1.67%	20.49%	-10.88%
Operating Cash Flow Q/Q Growth	56.45%	-26.18%	-43.19%	20.60%	38.46%	-0.67%	-47.14%	54.47%	10.25%	15.36%
Free Cash Flow Firm Q/Q Growth	-53.55%	-0.66%	-133.29%	-35.09%	-30.62%	-1.90%	2.19%	30.44%	20.14%	-0.52%
Invested Capital Q/Q Growth	3.13%	6.67%	11.08%	11.27%	7.37%	3.39%	6.31%	3.07%	4.63%	2.28%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	69.01%	66.10%	65.38%	64.22%	62.11%	59.63%	57.22%	57.85%	59.60%	57.75%
EBITDA Margin	56.73%	53.32%	52.41%	52.77%	51.63%	48.64%	48.37%	46.02%	50.28%	48.02%
Operating Margin	51.10%	46.60%	44.17%	43.52%	41.75%	37.60%	35.13%	32.65%	37.44%	34.36%
EBIT Margin	51.73%	47.69%	45.99%	46.15%	44.57%	40.37%	38.49%	36.05%	40.59%	37.16%
Profit (Net Income) Margin	43.79%	42.01%	39.00%	38.00%	37.71%	33.63%	30.18%	29.49%	32.81%	30.07%
Tax Burden Percent	86.34%	90.54%	87.77%	86.01%	88.92%	88.57%	85.46%	90.38%	87.64%	88.67%
Interest Burden Percent	98.05%	97.31%	96.62%	95.74%	95.15%	94.05%	91.77%	90.49%	92.23%	91.27%
Effective Tax Rate	13.66%	9.46%	12.23%	13.99%	11.08%	11.43%	14.54%	9.62%	12.36%	11.33%
Return on Invested Capital (ROIC)	75.93%	66.06%	54.47%	46.12%	41.68%	34.53%	27.56%	24.34%	24.96%	22.45%
ROIC Less NNEP Spread (ROIC-NNEP)	77.01%	66.76%	53.07%	55.97%	46.44%	35.68%	27.83%	24.31%	24.96%	22.08%
Return on Net Nonoperating Assets (RNNOA)	-9.23%	-5.57%	-2.72%	0.98%	1.67%	2.63%	3.78%	4.30%	5.46%	5.66%
Return on Equity (ROE)	66.70%	60.49%	51.74%	47.09%	43.36%	37.16%	31.34%	28.64%	30.41%	28.11%
Cash Return on Invested Capital (CROIC)	49.43%	46.39%	31.83%	19.75%	9.26%	6.71%	4.81%	7.47%	6.98%	6.76%
Operating Return on Assets (OROA)	42.34%	36.82%	32.92%	31.21%	27.98%	23.75%	20.17%	17.58%	19.05%	17.13%
Return on Assets (ROA)	35.84%	32.44%	27.92%	25.70%	23.68%	19.78%	15.82%	14.38%	15.40%	13.86%
Return on Common Equity (ROCE)	66.70%	60.49%	51.74%	47.09%	43.36%	37.16%	31.34%	28.64%	30.41%	28.11%
Return on Equity Simple (ROE_SIMPLE)	61.52%	0.00%	54.16%	48.22%	42.70%	0.00%	34.78%	30.86%	28.75%	0.00%
Net Operating Profit after Tax (NOPAT)	2,312	1,970	1,697	1,696	1,682	1,358	1,099	1,128	1,362	1,221
NOPAT Margin	44.12%	42.19%	38.76%	37.44%	37.12%	33.30%	30.02%	29.51%	32.81%	30.47%
Net Nonoperating Expense Percent (NNEP)	-1.08%	-0.70%	1.40%	-9.85%	-4.76%	-1.15%	-0.27%	0.03%	0.00%	0.37%
Return On Investment Capital (ROIC_SIMPLE)	-	8.45%	-	-	-	4.83%	-	-	-	4.00%
Cost of Revenue to Revenue	30.99%	33.90%	34.62%	35.78%	37.89%	40.37%	42.78%	42.15%	40.40%	42.25%
SG&A Expenses to Revenue	9.69%	4.71%	10.82%	10.17%	9.97%	10.74%	12.43%	12.17%	10.31%	11.13%
R&D to Revenue	8.22%	9.29%	10.39%	10.53%	10.39%	11.28%	13.06%	13.03%	11.85%	12.25%
Operating Expenses to Revenue	17.92%	19.51%	21.21%	20.70%	20.37%	22.03%	22.10%	25.20%	22.16%	23.38%
Earnings before Interest and Taxes (EBIT)	2,711	2,227	2,014	2,091	2,020	1,646	1,409	1,378	1,685	1,489
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,973	2,490	2,295	2,391	2,340	1,983	1,771	1,759	2,087	1,924
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	9.18	9.63	10.57	9.87	8.42	8.84	9.19	10.22	10.92	10.05
Price to Tangible Book Value (P/TBV)	13.22	13.94	15.00	13.76	11.54	12.14	12.60	13.94	14.88	13.82
Price to Revenue (P/Rev)	6.59	7.01	8.26	8.36	7.73	8.53	9.29	10.94	12.00	10.86
Price to Earnings (P/E)	14.98	16.11	19.60	20.57	19.82	23.07	26.55	33.30	38.17	35.56
Dividend Yield	3.16%	3.03%	2.69%	2.81%	3.22%	3.05%	2.96%	2.66%	2.52%	2.83%
Earnings Yield	6.67%	6.21%	5.10%	4.86%	5.05%	4.33%	3.77%	3.00%	2.62%	2.81%
Enterprise Value to Invested Capital (EV/IC)	9.88	9.83	10.22	9.03	7.53	7.78	7.69	8.41	8.65	7.67
Enterprise Value to Revenue (EV/Rev)	6.54	6.99	8.29	8.45	7.86	8.68	9.52	11.20	12.33	11.24
Enterprise Value to EBITDA (EV/EBITDA)	11.52	12.47	15.07	15.67	14.95	16.88	18.84	22.94	25.49	23.31
Enterprise Value to EBIT (EV/EBIT)	12.53	13.66	16.70	17.59	17.04	19.57	22.31	27.92	31.67	29.49
Enterprise Value to NOPAT (EV/NOPAT)	14.59	15.83	19.46	20.72	20.20	23.64	27.40	34.21	39.17	36.55
Enterprise Value to Operating Cash Flow (EV/OCF)	14.61	16.05	20.90	21.59	21.76	23.69	25.47	27.94	31.03	27.83
Enterprise Value to Free Cash Flow (EV/FCFF)	22.76	23.59	36.60	52.70	95.22	134.14	181.58	123.67	134.31	122.47
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.55	0.60	0.66	0.70	0.67	0.66	0.84	0.81	0.80	0.80
Long-Term Debt to Equity	0.51	0.56	0.63	0.69	0.66	0.63	0.76	0.75	0.74	0.76
Financial Leverage	-0.12	-0.08	-0.05	0.02	0.04	0.07	0.14	0.18	0.22	0.26
Leverage Ratio	1.85	1.86	1.86	1.85	1.85	1.89	1.99	1.99	1.98	2.01
Compound Leverage Factor	1.81	1.81	1.80	1.77	1.76	1.78	1.83	1.80	1.82	1.83
Debt to Total Capital	35.36%	37.47%	39.91%	41.31%	40.29%	39.91%	45.52%	44.66%	44.58%	44.58%
Short-Term Debt to Total Capital	2.22%	2.14%	1.97%	1.10%	1.08%	2.13%	4.33%	3.37%	3.37%	2.46%
Long-Term Debt to Total Capital	33.14%	35.33%	37.94%	40.21%	39.21%	37.78%	41.19%	41.29%	41.22%	42.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	64.64%	62.53%	60.09%	58.69%	59.71%	60.09%	54.48%	55.34%	55.42%	55.42%
Debt to EBITDA	0.69	0.78	0.94	1.11	1.18	1.25	1.67	1.77	1.83	1.80
Net Debt to EBITDA	-0.10	-0.03	0.05	0.16	0.24	0.29	0.45	0.54	0.68	0.80
Long-Term Debt to EBITDA	0.65	0.73	0.90	1.08	1.15	1.18	1.51	1.64	1.69	1.70
Debt to NOPAT	0.88	0.99	1.22	1.46	1.59	1.74	2.43	2.64	2.81	2.83
Net Debt to NOPAT	-0.13	-0.04	0.07	0.22	0.32	0.41	0.65	0.80	1.04	1.25
Long-Term Debt to NOPAT	0.82	0.93	1.16	1.42	1.55	1.65	2.20	2.44	2.60	2.67
Altman Z-Score	11.20	10.75	10.75	9.95	9.16	9.21	8.42	9.04	9.36	8.50
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.92	4.70	5.17	5.72	5.69	4.55	4.91	4.62	4.31	4.12
Quick Ratio	3.98	3.67	3.93	4.24	4.12	3.12	3.40	3.13	2.88	2.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-934	-940	-2,193	-2,962	-3,869	-3,942	-3,856	-2,682	-2,142	-2,153
Operating Cash Flow to CapEx	350.13%	211.17%	118.25%	96.82%	129.65%	167.60%	96.31%	147.93%	131.61%	167.76%
Free Cash Flow to Firm to Interest Expense	-17.62	-15.66	-32.24	-33.28	-39.48	-40.23	-33.24	-20.47	-16.35	-16.56
Operating Cash Flow to Interest Expense	52.19	34.03	17.06	15.72	19.77	19.63	8.77	11.99	13.22	15.37
Operating Cash Flow Less CapEx to Interest Expense	37.28	17.92	2.63	-0.52	4.52	7.92	-0.34	3.89	3.18	6.21
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.82	0.77	0.72	0.68	0.63	0.59	0.52	0.49	0.47	0.46
Accounts Receivable Turnover	10.93	11.14	10.62	9.08	9.02	9.52	9.47	8.78	8.19	8.92
Inventory Turnover	2.89	2.68	2.36	2.14	2.04	1.92	1.78	1.67	1.58	1.54
Fixed Asset Turnover	3.84	3.33	2.98	2.60	2.29	2.08	1.86	1.63	1.49	1.47
Accounts Payable Turnover	8.95	8.80	7.92	7.76	8.62	7.86	8.72	7.34	8.63	8.07
Days Sales Outstanding (DSO)	33.38	32.77	34.36	40.20	40.47	38.36	38.54	41.59	44.58	40.91
Days Inventory Outstanding (DIO)	126.50	136.12	154.68	170.53	178.96	189.69	205.38	218.64	230.34	237.67
Days Payable Outstanding (DPO)	40.79	41.48	46.07	47.03	42.33	46.41	41.88	49.70	42.31	45.21
Cash Conversion Cycle (CCC)	119.09	127.42	142.97	163.70	177.09	181.63	202.04	210.53	232.61	233.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	13,354	14,245	15,824	17,607	18,905	19,545	20,779	21,417	22,409	22,919
Invested Capital Turnover	1.72	1.57	1.41	1.23	1.12	1.04	0.92	0.82	0.76	0.74
Increase / (Decrease) in Invested Capital	3,246	2,910	3,890	4,658	5,551	5,300	4,955	3,810	3,504	3,374
Enterprise Value (EV)	131,986	139,990	161,674	159,024	142,291	152,067	159,866	180,174	193,749	175,810
Market Capitalization	133,139	140,322	161,093	157,357	140,017	149,419	156,070	175,971	188,608	169,794
Book Value per Share	$15.88	$16.06	$16.82	$17.56	$18.32	$18.60	$18.66	$18.91	$18.91	$18.53
Tangible Book Value per Share	$11.02	$11.09	$11.85	$12.60	$13.36	$13.56	$13.62	$13.86	$13.88	$13.47
Total Capital	22,444	23,312	25,369	27,159	27,853	28,120	31,172	31,105	31,161	30,499
Total Debt	7,937	8,735	10,126	11,219	11,222	11,223	14,189	13,891	13,893	13,596
Total Long-Term Debt	7,438	8,235	9,626	10,920	10,922	10,624	12,840	12,842	12,844	12,846
Net Debt	-1,153	-332	581	1,667	2,274	2,648	3,796	4,203	5,141	6,016
Capital Expenditures (CapEx)	790	967	981	1,445	1,494	1,148	1,056	1,062	1,316	1,191
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,383	2,469	3,074	3,550	3,797	3,826	4,851	4,513	4,483	4,553
Debt-free Net Working Capital (DFNWC)	11,473	11,536	12,619	13,102	12,745	12,401	15,244	14,201	13,235	12,133
Net Working Capital (NWC)	10,974	11,036	12,119	12,803	12,445	11,802	13,895	13,152	12,186	11,383
Net Nonoperating Expense (NNE)	17	8.15	-11	-26	-27	-13	-5.98	0.90	0.00	16
Net Nonoperating Obligations (NNO)	-1,153	-332	581	1,667	2,274	2,648	3,796	4,203	5,141	6,016
Total Depreciation and Amortization (D&A)	262	263	281	300	320	337	362	381	402	435
Debt-free, Cash-free Net Working Capital to Revenue	11.80%	12.33%	15.76%	18.86%	20.96%	21.84%	28.87%	28.05%	28.53%	29.11%
Debt-free Net Working Capital to Revenue	56.83%	57.60%	64.71%	69.61%	70.37%	70.79%	90.73%	88.25%	84.24%	77.57%
Net Working Capital to Revenue	54.35%	55.10%	62.14%	68.03%	68.71%	67.37%	82.70%	81.73%	77.56%	72.78%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.50	$2.16	$1.87	$1.89	$1.87	$1.50	$1.21	$1.23	$1.48	$1.32
Adjusted Weighted Average Basic Shares Outstanding	913M	916M	907M	908M	908M	908M	910M	912M	913M	912M
Adjusted Diluted Earnings per Share	$2.47	$2.14	$1.85	$1.87	$1.85	$1.50	$1.20	$1.22	$1.47	$1.31
Adjusted Weighted Average Diluted Shares Outstanding	923M	926M	916M	916M	916M	916M	917M	919M	920M	919M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	907.57M	906.21M	907.65M	907.97M	908.20M	909.29M	910.48M	913.05M	912.22M	910.33M
Normalized Net Operating Profit after Tax (NOPAT)	2,312	1,970	1,697	1,696	1,682	1,358	993	1,128	1,362	1,221
Normalized NOPAT Margin	44.12%	42.19%	38.76%	37.44%	37.12%	33.30%	27.13%	29.51%	32.81%	30.47%
Pre Tax Income Margin	50.72%	46.40%	44.44%	44.18%	42.41%	37.97%	35.32%	32.63%	37.44%	33.92%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	51.15	37.12	29.62	23.49	20.61	16.80	12.15	10.52	12.86	11.45
NOPAT to Interest Expense	43.63	32.84	24.96	19.06	17.17	13.85	9.47	8.61	10.40	9.39
EBIT Less CapEx to Interest Expense	36.25	21.00	15.19	7.26	5.37	5.08	3.04	2.41	2.82	2.29
NOPAT Less CapEx to Interest Expense	28.72	16.72	10.54	2.82	1.92	2.14	0.37	0.50	0.35	0.23
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	47.46%	49.11%	52.80%	57.55%	63.36%	70.00%	78.13%	88.01%	95.39%	99.92%
Augmented Payout Ratio	80.06%	90.43%	90.70%	83.91%	78.51%	74.50%	81.40%	91.49%	104.59%	119.27%

Frequently Asked Questions About Texas Instruments' Financials

When does Texas Instruments's financial year end?

According to the most recent income statement we have on file, Texas Instruments' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Texas Instruments' net income changed over the last 9 years?

Texas Instruments' net income appears to be on an upward trend, with a most recent value of $4.80 billion in 2024, rising from $2.99 billion in 2015. The previous period was $6.51 billion in 2023.

What is Texas Instruments's operating income?

Texas Instruments's total operating income in 2024 was $5.47 billion, based on the following breakdown:

Total Gross Profit: $9.09 billion
Total Operating Expenses: $3.63 billion

How has Texas Instruments revenue changed over the last 9 years?

Over the last 9 years, Texas Instruments' total revenue changed from $13 billion in 2015 to $15.64 billion in 2024, a change of 20.3%.

How much debt does Texas Instruments have?

Texas Instruments' total liabilities were at $18.61 billion at the end of 2024, a 20.4% increase from 2023, and a 196.1% increase since 2015.

How much cash does Texas Instruments have?

In the past 9 years, Texas Instruments' cash and equivalents has ranged from $1 billion in 2015 to $4.63 billion in 2021, and is currently $3.20 billion as of their latest financial filing in 2024.

How has Texas Instruments' book value per share changed over the last 9 years?

Over the last 9 years, Texas Instruments' book value per share changed from 9.80 in 2015 to 18.53 in 2024, a change of 89.0%.

Remove Ads

Related Companies

This page (NASDAQ:TXN) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Texas Instruments (TXN) Financials

Frequently Asked Questions About Texas Instruments' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Texas Instruments (TXN) Financials

Annual Income Statements for Texas Instruments

Quarterly Income Statements for Texas Instruments

Annual Cash Flow Statements for Texas Instruments

Quarterly Cash Flow Statements for Texas Instruments

Annual Balance Sheets for Texas Instruments

Quarterly Balance Sheets for Texas Instruments

Annual Metrics and Ratios for Texas Instruments

Quarterly Metrics and Ratios for Texas Instruments

Frequently Asked Questions About Texas Instruments' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools